Petersen PE: Oral cancer prevention and control-the approach of the World Health Organization. Oral Oncol. 45:454–460. 2009. View Article : Google Scholar : PubMed/NCBI

Petersen PE: World Health Organization global policy for improvement of oral health-World Health Assembly 2007. Int Dent J. 58:115–121. 2008. View Article : Google Scholar : PubMed/NCBI

Marthaler TM and Petersen PE: Salt fluoridation-an alternative in automatic prevention of dental caries. Int Dent J. 55:351–358. 2005. View Article : Google Scholar : PubMed/NCBI

Petersen PE: Tobacco and oral health-the role of the World Health Organization. Oral Health Prev Dent. 1:309–315. 2003.PubMed/NCBI

Petersen PE, Bourgeois D, Bratthall D and Ogawa H: Oral health information systems-towards measuring progress in oral health promotion and disease prevention. Bull World Health Organ. 83:686–693. 2005.PubMed/NCBI

Moynihan P and Petersen PE: Diet, nutrition and the prevention of dental diseases. Public Health Nutr. 7:201–226. 2004. View Article : Google Scholar : PubMed/NCBI

Moynihan PJ: The role of diet and nutrition in the etiology and prevention of oral diseases. Bull World Health Organ. 83:694–699. 2005.PubMed/NCBI

Oral Health Worldwide, . A report by FDI World Dental Federation. FDI World Dental Federation; Geneva: 2014

Nagpal M and Sood S: Role of curcumin in systemic and oral health: An overview. J Nat Sci Biol Med. 4:3–7. 2013. View Article : Google Scholar : PubMed/NCBI

Elattar TM and Virji AS: The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro. Anticancer Res. 20:1733–1738. 2000.PubMed/NCBI

Ramshankar V and Krishnamurthy A: Chemoprevention of oral cancer: Green tea experience. J Nat Sci Biol Med. 5:3–7. 2014. View Article : Google Scholar : PubMed/NCBI

Duan J, Yue W, E J, Malhotra J, Lu SE, Gu J, Xu F and Tan XL: In vitro comparative studies of resveratrol and triacetylresveratrol on cell proliferation, apoptosis, and STAT3 and NFκB signaling in pancreatic cancer cells. Sci Rep. 6:316722016. View Article : Google Scholar : PubMed/NCBI

Tao W, Xu X, Wang X, Li B, Wang Y, Li Y and Yang L: Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. J Ethnopharmacol. 145:1–10. 2013. View Article : Google Scholar : PubMed/NCBI

Jiang M, Lu C, Chen G, Xiao C, Zha Q, Niu X, Chen S and Lu A: Understanding the molecular mechanism of interventions in treating rheumatoid arthritis patients with corresponding traditional Chinese medicine patterns based on bioinformatics approach. Evid Based Complement Alternat Med. 2012:1294522012. View Article : Google Scholar : PubMed/NCBI

Li S and Zhang B: Traditional Chinese medicine network pharmacology: Theory, methodology and application. Chin J Nat Med. 11:110–120. 2013. View Article : Google Scholar : PubMed/NCBI

Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S and Takada Y: Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res. 24:2783–2840. 2004.PubMed/NCBI

Pervaiz S and Holme AL: Resveratrol: Its biologic targets and functional activity. Antioxid Redox Signal. 11:2851–2897. 2009. View Article : Google Scholar : PubMed/NCBI

Harikumar KB and Aggarwal BB: Resveratrol: A multitargeted agent for age-associated chronic diseases. Cell Cycle. 7:1020–1035. 2008. View Article : Google Scholar : PubMed/NCBI

Athar M, Back JH, Kopelovich L, Bickers DR and Kim AL: Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Arch Biochem Biophys. 486:95–102. 2009. View Article : Google Scholar : PubMed/NCBI

Kerem Z, Chetrit D, Shoseyov O and Regev-Shoshani G: Protection of lipids from oxidation by epicatechin, trans-resveratrol, and gallic and caffeic acids in intestinal model systems. J Agric Food Chem. 54:10288–10293. 2006. View Article : Google Scholar : PubMed/NCBI

Murias M, Handler N, Erker T, Pleban K, Ecker G, Saiko P, Szekeres T and Jäger W: Resveratrol analogues as selective cyclooxygenase-2 inhibitors: Synthesis and structure-activity relationship. Bioorg Med Chem. 12:5571–5578. 2004. View Article : Google Scholar : PubMed/NCBI

Gehm BD, McAndrews JM, Chien PY and Jameson JL: Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA. 94:pp. 14138–14143. 1997; View Article : Google Scholar : PubMed/NCBI

Kraft TE, Parisotto D, Schempp C and Efferth T: Fighting cancer with red wine? Molecular mechanisms of resveratrol. Crit Rev Food Sci Nutr. 49:782–799. 2009. View Article : Google Scholar : PubMed/NCBI

Benová B, Adam M, Onderková K, Královsky J and Krajicek M: Analysis of selected stilbenes in Polygonum cuspidatum by HPLC coupled with CoulArray detection. J Sep Sci. 31:2404–2409. 2008. View Article : Google Scholar : PubMed/NCBI

Wu JM, Wang ZR, Hsieh TC, Bruder JL, Zou JG and Huang YZ: Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (Review). Int J Mol Med. 8:3–17. 2001.PubMed/NCBI

Jung JC, Lim E, Lee Y, Kang JM, Kim H, Jang S, Oh S and Jung M: Synthesis of novel trans-stilbene derivatives and evaluation of their potent antioxidant and neuroprotective effects. Eur J Med Chem. 44:3166–3174. 2009. View Article : Google Scholar : PubMed/NCBI

King RE, Kent KD and Bomser JA: Resveratrol reduces oxidation and proliferation of human retinal pigment epithelial cells via extracellular signal-regulated kinase inhibition. Chem Biol Interact. 151:143–149. 2005. View Article : Google Scholar : PubMed/NCBI

Saiko P, Szakmary A, Jaeger W and Szekeres T: Resveratrol and its analogs: Defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat Res. 658:68–94. 2008. View Article : Google Scholar : PubMed/NCBI

Szekeres T, Fritzer-Szekeres M, Saiko P and Jäger W: Resveratrol and resveratrol analogues-structure-activity relationship. Pharm Res. 27:1042–1048. 2010. View Article : Google Scholar : PubMed/NCBI

Szekeres T, Saiko P, Fritzer-Szekeres M, Djavan B and Jäger W: Chemopreventive effects of resveratrol and resveratrol derivatives. Ann N Y Acad Sci. 1215:89–95. 2011. View Article : Google Scholar : PubMed/NCBI

Piotrowska H, Kucinska M and Murias M: Biological activity of piceatannol: Leaving the shadow of resveratrol. Mutat Res. 750:60–82. 2012. View Article : Google Scholar : PubMed/NCBI

Petrovski G, Gurusamy N and Das DK: Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci. 1215:22–33. 2011. View Article : Google Scholar : PubMed/NCBI

Ndiaye M, Philippe C, Mukhtar H and Ahmad N: The grape antioxidant resveratrol for skin disorders: Promise, prospects, and challenges. Arch Biochem Biophys. 508:164–170. 2011. View Article : Google Scholar : PubMed/NCBI

Szkudelska K and Szkudelski T: Resveratrol, obesity and diabetes. Eur J Pharmacol. 635:1–8. 2010. View Article : Google Scholar : PubMed/NCBI

Wahba MG, Messiha BA and Abo-Saif AA: Protective effects of fenofibrate and resveratrol in an aggressive model of rheumatoid arthritis in rats. Pharm Biol. 54:1705–1715. 2016. View Article : Google Scholar : PubMed/NCBI

Bastianetto S, Ménard C and Quirion R: Neuroprotective action of resveratrol. Biochim Biophys Acta. 1852:1195–1201. 2015. View Article : Google Scholar : PubMed/NCBI

Markus MA and Morris BJ: Resveratrol in prevention and treatment of common clinical conditions of aging. Clin Interv Aging. 3:331–339. 2008.PubMed/NCBI

Frémont L: Biological effects of resveratrol. Life Sci. 66:663–673. 2000. View Article : Google Scholar : PubMed/NCBI

Wang W, Tang K, Yang HR, Wen PF, Zhang P, Wang HL and Huang WD: Distribution of resveratrol and stilbene synthase in young grape plants (Vitis vinifera L. cv. Cabernet Sauvignon) and the effect of UV-C on its accumulation. Plant Physiol Biochem. 48:142–152. 2010. View Article : Google Scholar : PubMed/NCBI

Soleas GJ, Diamandis EP and Goldberg DM: Resveratrol: A molecule whose time has come? And gone? Clin Biochem. 30:91–113. 1997. View Article : Google Scholar : PubMed/NCBI

Vastano BC, Chen Y, Zhu N, Ho CT, Zhou Z and Rosen RT: Isolation and identification of stilbenes in two varieties of Polygonum cuspidatum. J Agric Food Chem. 48:253–256. 2000. View Article : Google Scholar : PubMed/NCBI

Hathway DE and Seakins JW: Hydroxystilbenes of Eucalyptus wandoo. Biochem J. 72:369–374. 1959. View Article : Google Scholar : PubMed/NCBI

Rolfs CH and Kindl H: Stilbene synthase and chalcone synthase: Two different constitutive enzymes in cultured cells of Picea excelsa. Plant Physiol. 75:489–492. 1984. View Article : Google Scholar : PubMed/NCBI

King RE, Bomser JA and Min DB: Bioactivity of resveratrol. Comprehensive Reviews in Food Science and Food Safety. 5:65–70. 2006. View Article : Google Scholar

Takaoka MJ: The phenolic substances of white hellebore (Veratrum grandiflorum Loes. fil.). J Faculty Sci. 3:1–16. 1940.

Baur JA and Sinclair DA: Therapeutic potential of resveratrol: The in vivo evidence. Nat Rev Drug Discov. 5:493–506. 2006. View Article : Google Scholar : PubMed/NCBI

Langcake P and Pryce RJ: A new class of phytoalexins from grapevines. Experientia. 33:151–152. 1977. View Article : Google Scholar : PubMed/NCBI

Renaud S and de Lorgeril M: Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 339:1523–1526. 1992. View Article : Google Scholar : PubMed/NCBI

Counet C, Callemien D and Collin S: Chocolate and cocoa: New sources of trans-resveratrol and trans-piceid. Food Chemistry. 98:649–657. 2006. View Article : Google Scholar

Wang Y, Catana F, Yang Y, Roderick R and van Breemen RB: An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine. J Agric Food Chem. 50:431–435. 2002. View Article : Google Scholar : PubMed/NCBI

Siemann EH and Creasy LL: Concentration of the Phytoalexin resveratrol in wine. Am J Enol Vitic. 43:49–52. 1992.

Guerrero RF, Garcia-Parrilla MC, Puertas B and Cantos-Villar E: Wine, resveratrol and health: A review. Nat Prod Commun. 4:635–658. 2009.PubMed/NCBI

Stervbo U, Vang O and Bonnesen C: A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine. Food Chemistry. 101:449–457. 2007. View Article : Google Scholar

Figueiras TS, Neves-Petersen MT and Petersen SB: Activation energy of light induced isomerization of resveratrol. J Fluoresc. 21:1897–1906. 2011. View Article : Google Scholar : PubMed/NCBI

Cai YJ, Wei QY, Fang JG, Yang L, Liu ZL, Wyche JH and Han Z: The 3,4-dihydroxyl groups are important for trans-resveratrol analogs to exhibit enhanced antioxidant and apoptotic activities. Anticancer Res. 24:999–1002. 2004.PubMed/NCBI

Wieder T, Prokop A, Bagci B, Essmann F, Bernicke D, Schulze-Osthoff K, Dörken B, Schmalz HG, Daniel PT and Henze G: Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts. Leukemia. 15:1735–1742. 2001. View Article : Google Scholar : PubMed/NCBI

Yang T, Wang L, Zhu M, Zhang L and Yan L: Properties and molecular mechanisms of resveratrol: A review. Pharmazie. 70:501–506. 2015.PubMed/NCBI

Biasutto L, Marotta E, Bradaschia A, Fallica M, Mattarei A, Garbisa S, Zoratti M and Paradisi C: Soluble polyphenols: Synthesis and bioavailability of 3,4′,5-tri(alpha-D-glucose-3-O-succinyl) resveratrol. Bioorg Med Chem Lett. 19:6721–6724. 2009. View Article : Google Scholar : PubMed/NCBI

Ratnam DV, Ankola DD, Bhardwaj V, Sahana DK and Kumar MN: Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. J Control Release. 113:189–207. 2006. View Article : Google Scholar : PubMed/NCBI

Lin YL, Chang HC, Chen TL, Chang JH, Chiu WT, Lin JW and Chen RM: Resveratrol protects against oxidized LDL-induced breakage of the blood-brain barrier by lessening disruption of tight junctions and apoptotic insults to mouse cerebrovascular endothelial cells. J Nutr. 140:2187–2192. 2010. View Article : Google Scholar : PubMed/NCBI

Du QH, Peng C and Zhang H: Polydatin: A review of pharmacology and pharmacokinetics. Pharm Biol. 51:1347–1354. 2013. View Article : Google Scholar : PubMed/NCBI

Plou FJ, Segura AGd and Ballesteros A: Application of Glycosidases and Transglycosidases in the synthesis of oligosaccharidesIndustrial enzymes: Structure, function and applications. Polaina J and MacCabe AP: Springer; Netherlands, Dordrecht: pp. 141–157. 2007, View Article : Google Scholar

Bertrand A, Morel S, Lefoulon F, Rolland Y, Monsan P and Remaud-Simeon M: Leuconostoc mesenteroides glucansucrase synthesis of flavonoid glucosides by acceptor reactions in aqueous-organic solvents. Carbohydr Res. 341:855–863. 2006. View Article : Google Scholar : PubMed/NCBI

Cichewicz RH and Kouzi SA: Biotransformation of resveratrol to piceid by Bacillus cereus. J Nat Prod. 61:1313–1314. 1998. View Article : Google Scholar : PubMed/NCBI

Baek SJ, Wilson LC and Eling TE: Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis. 23:425–434. 2002. View Article : Google Scholar : PubMed/NCBI

Aziz MH, Kumar R and Ahmad N: Cancer chemoprevention by resveratrol: In vitro and in vivo studies and the underlying mechanisms (review). Int J Oncol. 23:17–28. 2003.PubMed/NCBI

Walle T, Hsieh F, DeLegge MH, Oatis JE Jr and Walle UK: High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 32:1377–1382. 2004. View Article : Google Scholar : PubMed/NCBI

Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP and Ducharme MP: Metabolism and disposition of resveratrol in rats: Extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther. 302:369–373. 2002. View Article : Google Scholar : PubMed/NCBI

Belguendouz L, Fremont L and Linard A: Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem Pharmacol. 53:1347–1355. 1997. View Article : Google Scholar : PubMed/NCBI

Jannin B, Menzel M, Berlot JP, Delmas D, Lancon A and Latruffe N: Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: Plasmatic protein binding and cell uptake. Biochem Pharmacol. 68:1113–1118. 2004. View Article : Google Scholar : PubMed/NCBI

Lançon A, Delmas D, Osman H, Thénot JP, Jannin B and Latruffe N: Human hepatic cell uptake of resveratrol: Involvement of both passive diffusion and carrier-mediated process. Biochem Biophys Res Commun. 316:1132–1137. 2004. View Article : Google Scholar : PubMed/NCBI

Lucas R, Alcantara D and Morales JC: A concise synthesis of glucuronide metabolites of urolithin-B, resveratrol, and hydroxytyrosol. Carbohydr Res. 344:1340–1346. 2009. View Article : Google Scholar : PubMed/NCBI

Bertelli AA, Giovannini L, Stradi R, Bertelli A and Tillement JP: Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4′,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int J Tissue React. 18:67–71. 1996.PubMed/NCBI

El Mohsen MA, Marks J, Kuhnle G, Moore K, Debnam E, Srai S Kaila, Rice-Evans C and Spencer JP: Absorption, tissue distribution and excretion of pelargonidin and its metabolites following oral administration to rats. Br J Nutr. 95:51–58. 2006. View Article : Google Scholar : PubMed/NCBI

Vitrac X, Desmoulière A, Brouillaud B, Krisa S, Deffieux G, Barthe N, Rosenbaum J and Mérillon JM: Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci. 72:2219–2233. 2003. View Article : Google Scholar : PubMed/NCBI

de Santi C, Pietrabissa A, Spisni R, Mosca F and Pacifici GM: Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum. Xenobiotica. 30:609–617. 2000. View Article : Google Scholar : PubMed/NCBI

Koga CC, Andrade JE, Ferruzzi MG and Lee Y: Stability of trans-resveratrol encapsulated in a protein matrix produced using spray drying to UV light stress and simulated gastro-intestinal digestion. J Food Sci. 81:C292–C300. 2016. View Article : Google Scholar : PubMed/NCBI

Teskac K and Kristl J: The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int J Pharm. 390:61–69. 2010. View Article : Google Scholar : PubMed/NCBI

Nam JB, Ryu JH, Kim JW, Chang IS and Suh KD: Stabilization of resveratrol immobilized in monodisperse cyano-functionalized porous polymeric microspheres. Polymer. 46:8956–8963. 2005. View Article : Google Scholar

Shi G, Rao L, Yu H, Xiang H, Yang H and Ji R: Stabilization and encapsulation of photosensitive resveratrol within yeast cell. Int J Pharm. 349:83–93. 2008. View Article : Google Scholar : PubMed/NCBI

Kesisoglou F, Panmai S and Wu Y: Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev. 59:631–644. 2007. View Article : Google Scholar : PubMed/NCBI

Rasenack N and Müller BW: Crystal habit and tableting behavior. Int J Pharm. 244:45–57. 2002. View Article : Google Scholar : PubMed/NCBI

Juan ME, Vinardell MP and Planas JM: The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J Nutr. 132:257–260. 2002.PubMed/NCBI

Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK and Shi X: Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun. 309:1017–1026. 2003. View Article : Google Scholar : PubMed/NCBI

Halliwell B and Gutteridge JM: Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol. 186:1–85. 1990. View Article : Google Scholar : PubMed/NCBI

Rizvi SI and Pandey KB: Activation of the erythrocyte plasma membrane redox system by resveratrol: A possible mechanism for antioxidant properties. Pharmacol Rep. 62:726–732. 2010. View Article : Google Scholar : PubMed/NCBI

Das S and Das DK: Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets. 6:168–173. 2007. View Article : Google Scholar : PubMed/NCBI

Birben E, Sahiner UM, Sackesen C, Erzurum S and Kalayci O: Oxidative stress and antioxidant defense. World Allergy Organ J. 5:9–19. 2012. View Article : Google Scholar : PubMed/NCBI

Simon HU, Haj-Yehia A and Levi-Schaffer F: Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 5:415–418. 2000. View Article : Google Scholar : PubMed/NCBI

Kim CH, Jeon HM, Lee SY, Jeong EK, Ju MK, Park BJ, Park HG, Lim SC, Han SI and Kang HS: Role of reactive oxygen species-dependent protein aggregation in metabolic stress-induced necrosis. Int J Oncol. 37:97–102. 2010.PubMed/NCBI

la Lastra CA and Villegas I: Resveratrol as an antioxidant and pro-oxidant agent: Mechanisms and clinical implications. Biochem Soc Trans. 35:1156–1160. 2007. View Article : Google Scholar : PubMed/NCBI

Azmi AS, Bhat SH, Hanif S and Hadi SM: Plant polyphenols mobilize endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: A putative mechanism for anticancer properties. FEBS Lett. 580:533–538. 2006. View Article : Google Scholar : PubMed/NCBI

Jang M and Pezzuto JM: Cancer chemopreventive activity of resveratrol. Drugs Exp Clin Res. 25:65–77. 1999.PubMed/NCBI

Cao Z and Li Y: Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: Protection against oxidative and electrophilic injury. Eur J Pharmacol. 489:39–48. 2004. View Article : Google Scholar : PubMed/NCBI

Yen GC, Duh PD and Lin CW: Effects of resveratrol and 4-hexylresorcinol on hydrogen peroxide-induced oxidative DNA damage in human lymphocytes. Free Radic Res. 37:509–514. 2003. View Article : Google Scholar : PubMed/NCBI

Melov S: Therapeutics against mitochondrial oxidative stress in animal models of aging. Ann N Y Acad Sci. 959:330–340. 2002. View Article : Google Scholar : PubMed/NCBI

Ates O, Cayli SR, Yucel N, Altinoz E, Kocak A, Durak MA, Turkoz Y and Yologlu S: Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats. J Clin Neurosci. 14:256–260. 2007. View Article : Google Scholar : PubMed/NCBI

Belguendouz L, Frémont L and Gozzelino MT: Interaction of transresveratrol with plasma lipoproteins. Biochem Pharmacol. 55:811–816. 1998. View Article : Google Scholar : PubMed/NCBI

Rotondo S, Rajtar G, Manarini S, Celardo A, Rotillo D, De Gaetano G, Evangelista V and Cerletti C: Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol. 123:1691–1699. 1998. View Article : Google Scholar : PubMed/NCBI

West JD and Marnett LJ: Endogenous reactive intermediates as modulators of cell signaling and cell death. Chem Res Toxicol. 19:173–194. 2006. View Article : Google Scholar : PubMed/NCBI

Lee HS, Kim HN, Jung MH and Choi JY: Electrically evoked potentials recorded in a patient with auditory neuropathy. Cochlear Implants Int. 5 Suppl 1:S2312004. View Article : Google Scholar

Rizvi SI and Maurya PK: Alterations in antioxidant enzymes during aging in humans. Mol Biotechnol. 37:58–61. 2007. View Article : Google Scholar : PubMed/NCBI

Wenzel U, Nickel A and Daniel H: Increased mitochondrial palmitoylcarnitine/carnitine countertransport by flavone causes oxidative stress and apoptosis in colon cancer cells. Cell Mol Life Sci. 62:3100–3105. 2005. View Article : Google Scholar : PubMed/NCBI

Guo R, Su Y, Liu B, Li S, Zhou S and Xu Y: Resveratrol suppresses oxidised low-density lipoprotein-induced macrophage apoptosis through inhibition of intracellular reactive oxygen species generation, LOX-1, and the p38 MAPK pathway. Cell Physiol Biochem. 34:603–616. 2014. View Article : Google Scholar : PubMed/NCBI

Dani C, Bonatto D, Salvador M, Pereira MD, Henriques JA and Eleutherio E: Antioxidant protection of resveratrol and catechin in Saccharomyces cerevisiae. J Agric Food Chem. 56:4268–4272. 2008. View Article : Google Scholar : PubMed/NCBI

Naylor AJ Dirks: Cellular effects of resveratrol in skeletal muscle. Life Sci. 84:637–640. 2009. View Article : Google Scholar : PubMed/NCBI

Pandey KB and Rizvi SI: Protective effect of resveratrol on formation of membrane protein carbonyls and lipid peroxidation in erythrocytes subjected to oxidative stress. Appl Physiol Nutr Metab. 34:1093–1097. 2009. View Article : Google Scholar : PubMed/NCBI

Pandey KB and Rizvi SI: Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev. 2:270–278. 2009. View Article : Google Scholar : PubMed/NCBI

Rizvi SI, Jha R and Pandey KB: Activation of erythrocyte plasma membrane redox system provides a useful method to evaluate antioxidant potential of plant polyphenols. Methods Mol Biol. 594:341–348. 2010. View Article : Google Scholar : PubMed/NCBI

Goldberg DM, Yan J and Soleas GJ: Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem. 36:79–87. 2003. View Article : Google Scholar : PubMed/NCBI

Perrone D, Ardito F, Giannatempo G, Dioguardi M, Troiano G, Lo Russo L, De Lillo A, Laino L and Lo Muzio L: Biological and therapeutic activities, and anticancer properties of curcumin. Exp Ther Med. 10:1615–1623. 2015.PubMed/NCBI

Maioli E, Torricelli C and Valacchi G: Rottlerin and cancer: Novel evidence and mechanisms. Scientific World Journal. 2012:3508262012. View Article : Google Scholar : PubMed/NCBI

Russo M, Russo GL, Daglia M, Kasi PD, Ravi S, Nabavi SF and Nabavi SM: Understanding genistein in cancer: The ‘good’ and the ‘bad’ effects: A review. Food Chem. 196:589–600. 2016. View Article : Google Scholar : PubMed/NCBI

Brito AF, Ribeiro M, Abrantes AM, Pires AS, Teixo RJ, Tralhão JG and Botelho MF: Quercetin in cancer treatment, alone or in combination with conventional therapeutics? Curr Med Chem. 22:3025–3039. 2015. View Article : Google Scholar : PubMed/NCBI

Zhao X and Zhang J: Mechanisms for quercetin in prevention of lung cancer cell growth and metastasis. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 40:592–597. 2015.(In Chinese). PubMed/NCBI

Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML, Nawroth R, Sanchez-Garcia I, et al: Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol. 35 Suppl:S25–S54. 2015. View Article : Google Scholar : PubMed/NCBI

Yu XD, Yang JL, Zhang WL and Liu DX: Resveratrol inhibits oral squamous cell carcinoma through induction of apoptosis and G2/M phase cell cycle arrest. Tumour Biol. 37:2871–2877. 2016. View Article : Google Scholar : PubMed/NCBI

Ray JG, Ranganathan K and Chattopadhyay A: Malignant transformation of oral submucous fibrosis: Overview of histopathological aspects. Oral Surg Oral Med Oral Pathol Oral Radiol. 122:200–209. 2016. View Article : Google Scholar : PubMed/NCBI

Sharma M and Radhakrishnan R: Limited mouth opening in oral submucous fibrosis: Reasons, ramifications, and remedies. J Oral Pathol Med. Oct 15–2016.(Epub ahead of print). View Article : Google Scholar

Chang YC, Lin CW, Yu CC, Wang BY, Huang YH, Hsieh YC, Kuo YL and Chang WW: Resveratrol suppresses myofibroblast activity of human buccal mucosal fibroblasts through the epigenetic inhibition of ZEB1 expression. Oncotarget. 7:12137–12149. 2016.PubMed/NCBI

Mohan A, Narayanan S, Balasubramanian G, Sethuraman S and Krishnan UM: Dual drug loaded nanoliposomal chemotherapy: A promising strategy for treatment of head and neck squamous cell carcinoma. Eur J Pharm Biopharm. 99:73–83. 2016. View Article : Google Scholar : PubMed/NCBI

ElAttar TM and Virji AS: Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anticancer Drugs. 10:187–193. 1999. View Article : Google Scholar : PubMed/NCBI

Lin FY, Hsieh YH, Yang SF, Chen CT, Tang CH, Chou MY, Chuang YT, Lin CW and Chen MK: Resveratrol suppresses TPA-induced matrix metalloproteinase-9 expression through the inhibition of MAPK pathways in oral cancer cells. J Oral Pathol Med. 44:699–706. 2015. View Article : Google Scholar : PubMed/NCBI

Masuelli L, Di Stefano E, Fantini M, Mattera R, Benvenuto M, Marzocchella L, Sacchetti P, Focaccetti C, Bernardini R, Tresoldi I, et al: Resveratrol potentiates the in vitro and in vivo anti-tumoral effects of curcumin in head and neck carcinomas. Oncotarget. 5:10745–10762. 2014. View Article : Google Scholar : PubMed/NCBI

Shan Z, Yang G, Xiang W, Pei-Jun W and Bin Z: Effects of resveratrol on oral squamous cell carcinoma (OSCC) cells in vitro. J Cancer Res Clin Oncol. 140:371–374. 2014. View Article : Google Scholar : PubMed/NCBI